Antibiotic dosing for multidrug-resistant pathogen pneumonia

by Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Roberts, Jason A.
Published 2017

Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

by Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Roberts, Jason A.
Published 2017

Defining antibiotic dosing in lung infections

by Jamal, Jannatul-Ain, Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Roberts, Jason A.
Published 2013

Continuous beta-lactam infusion in critically ill patients: the clinical evidence

by Abdul Aziz, Mohd. Hafiz, Dulhunty, Joel M., Bellomo, Rinaldo, Lipman, Jeffrey, Roberts, Jason A.
Published 2012

Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development

by Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Mouton, Johan W., Hope, William W., Roberts, Jason A.
Published 2015

Infections by multidrug-resistant Gram-negative bacteria: what's new in our arsenal and what's in the pipeline?

by Koulenti, Despoina, Song, Andrew, Ellingboe, Aaron, Abdul-Aziz, Mohd Hafiz, Harris, Patrick, Gavey, Emile S., Lipman, Jeffrey
Published 2019

Plasma & subcutaneous tissue pharmacokinetics of piperacillin in a large cohort of critically ill patients with sepsis

by Abdul Aziz, Mohd. Hafiz, Udy, Andrew A., Wallis, Steven C., Roberts, Michael S., Lipman, Jeffrey, Roberts, Jason A.
Published 2014

Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU

by Abdul Aziz, Mohd. Hafiz, McDonald, Craig, McWhinney, Brett, Ungerer , Jacobus P., Lipman, Jeffrey, Roberts, Jason A.
Published 2014

A national survey of renal replacement therapy prescribing practice for acute kidney injury in Malaysian intensive care units

by Jamal, Janatltul Ain, Mat Nor, Mohd Basri, Mohamad Nor, Fariz Safhan, Udy, Andrew A Udy, Lipman, Jeffrey, Roberts, Jason A.
Published 2014

Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials

by Roberts, Jason A., Abdul Aziz, Mohd. Hafiz, Davis, Joshua S., Dulhunty, Joel M., Cotta, Menino O., Myburgh, John, Bellomo, Rinaldo, Lipman, Jeffrey
Published 2016

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomized controlled trial of continuous infusion versus intermittent b...

by Jamal, Janattul-Ain, Mat Nor, Mohd Basri, Mohamad Nor, Fariz Safhan, Udy, Andrew A, Wallis, Steven C, Lipman, Jeffrey, Roberts, Jason A.
Published 2015

Population pharmacokinetics of doripenem in critically ill patients with sepsis in a Malaysian intensive care unit

by Abdul Aziz, Mohd. Hafiz, Abd. Rahman, Nurul Azrin, Mat Nor, Mohd Basri, Sulaiman, Helmi, Wallis, Steven C., Lipman, Jeffrey, Roberts, Jason A., Staatz, Christine E.
Published 2016

Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermitten...

by Jamal, Janattul-Ain, Roberts, Darren M., Udy, Andrew A, Mat Nor, Mohd Basri, Mohamad Nor, Fariz Safhan, Wallis, Steven C, Lipman, Jeffrey, Roberts, Jason A.
Published 2015

Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis

by Rhodes, Nathaniel J., Liu, Jiajun, O'Donnell, J. Nicholas, Dulhunty, Joel M., Abdul Aziz, Mohd. Hafiz, Berko, Patsy Y., Nadler, Barbara, Lipman, Jeffrey, Roberts, Jason A.
Published 2018

What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?

by Alobaid, Abdulaziz S., Brinkmann, Alexander, Frey, Otto R., Roehr, Anka C., Luque, Sonia, Grau, Santiago, Wong , Gloria, Abdul Aziz, Mohd. Hafiz, Roberts, Michael S., Lipman, Jeffrey, Roberts, Jason A.
Published 2015

The BLISS study: Beta-Lactam infusion in severe sepsis-randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sep...

by Abdul Aziz, Mohd. Hafiz, Sulaiman, Helmi, Mat Nor, Mohd Basri, Rai, Vineya, Wong, K., Hasan, Mohd Shahnaz, Wallis, Steven C, Lipman, Jeffrey, Staatz, Christine E., Roberts, Jason A.
Published 2015

Molecular analysis of the acinetobacter baumannii biofilm-associated protein

by Sidjabat, Hanna E., Paterson, David L., Nimmo, Graeme R., Lipman, Jeffrey, Schembri, Mark A., Goh, Hwee Mian Sharon, Beatson, Scott A., Totsika, Makrina, Moriel, Danilo G., Phan, Minh-Duy, Szubert, Jan, Runnegar, Naomi
Published 2015

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critic...

by Abdul Aziz, Mohd. Hafiz, Sulaiman, Helmi, Mat Nor, Mohd Basri, Rai, Vineya, Wong, K., Hasan, Mohd Shahnaz, Abd. Rahman, Nurul Azrin, Jamal, Janattul-Ain, Wallis, Steven C., Lipman, Jeffrey, Staatz, Christine E., Roberts, Jason A.
Published 2016

The DALI study: defining antibiotic levels in intensive care unit patients: prolonged infusion of beta-lactam antibiotics in critically ill patients

by Abdul Aziz, Mohd. Hafiz, Roberts, Jason A., Akova, Murat, Basetti, Matteo, De Waele, Jan, Dimopoulos, George, Kaukonen, Maija, Koulenti, Despoina, Martin, Claude, Montravers, Paul, Rello, Jordi, Rhodes, Alan, Starr, Therese, Wallis, Steven C., Lipman, Jeffrey
Published 2013

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

by Roberts, Jason A., Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Mouton, Johan W., Vinks, Alexander A., Felton, Timothy W., Hope, William W., Farkas, Andras, Neely , Michael N., Schentag, Jerome J., Drusano, George, Frey, Otto R., Theuretzbacher, Ursula, Kuti, Joseph L.
Published 2014